Table 3.
Reasons for discontinuing TFM.
Characteristics | Baseline-Month 24 (n = 27) |
---|---|
Clinical Progression | 1 |
Clinical Progression and Clinical Relapse | 2 |
Clinical Progression, Clinical Relapse, and New MRI Activity | 1 |
Clinical Relapse | 1 |
Clinical Relapse and New MRI Activity | 3 |
New MRI Activity | 4 |
New MRI Activity and Non-Compliance with TFM | 1 |
Adverse Events | 5 |
Subject Discretion | 6 |
Non-Compliance with TFM | 2 |
Lost to Follow-up | 1 |